Lin Patrick — SEC Form 4 filings

SEC reporting owner CIK 1799363. 18 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2024-02-01 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy Off1810 legs · 58,871 sh · $72,67121

Form 4 filings — Lin Patrick

FiledFormIssuerReported transactionsSource
2026-07-284Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 8,450 (derivative) @ $0EDGAR
2026-07-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,106 @ $1.93EDGAR
2026-06-164Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,831 @ $2.22EDGAR
2026-06-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,582 @ $2.57EDGAR
2026-05-194Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,369 @ $2.97EDGAR
2026-05-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,511 @ $2.69EDGAR
2026-04-174Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,369 @ $2.97EDGAR
2026-04-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,603 @ $2.54EDGAR
2026-02-044Processa Pharmaceuticals, Inc. (PCSA)Option exercise (M): 193 @ $0 · Option exercise (M): 193 (derivative) @ $0EDGAR
2025-10-034Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 68,000 (derivative) @ $0 · Grant/award (A): 204,000 (derivative) @ $0EDGAR
2025-09-184/AProcessa Pharmaceuticals, Inc. (PCSA)Holdings only — no transactions reportedEDGAR
2025-07-284Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 1,401,650 (derivative) @ $0EDGAR
2025-04-114Processa Pharmaceuticals, Inc. (PCSA)Option exercise (M): 14,482 · Tax withholding (F): 4,814 @ $0.41EDGAR
2025-02-184/AProcessa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 43,500 (derivative) @ $0 · Grant/award (A): 21,750 (derivative) @ $0EDGAR
2025-01-294Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 43,500 @ $0.80EDGAR
2024-08-024Processa Pharmaceuticals, Inc. (PCSA)Option exercise (M): 1,675 · Tax withholding (F): 539 @ $2.79 · Option exercise (M): 644 · Tax withholding (F): 271 @ $1.71 · Grant/award (A): 2,713 (derivative) @ $0 · Grant/award (A): 2,035 (derivative) @ $0 · +2 moreEDGAR
2024-04-124Processa Pharmaceuticals, Inc. (PCSA)Option exercise (M): 1,675 · Tax withholding (F): 539 @ $2.79 · Option exercise (M): 1,675 (derivative) @ $0EDGAR
2024-02-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,500 @ $2.37 · Purchase (P): 1,500 @ $2.40EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1799363 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →